385 related articles for article (PubMed ID: 16004672)
1. Emerging concepts in osteoporosis and bone strength.
Rubin CD
Curr Med Res Opin; 2005 Jul; 21(7):1049-56. PubMed ID: 16004672
[TBL] [Abstract][Full Text] [Related]
2. The bone quality framework: determinants of bone strength and their interrelationships, and implications for osteoporosis management.
Felsenberg D; Boonen S
Clin Ther; 2005 Jan; 27(1):1-11. PubMed ID: 15763602
[TBL] [Abstract][Full Text] [Related]
3. Important determinants of bone strength: beyond bone mineral density.
Friedman AW
J Clin Rheumatol; 2006 Apr; 12(2):70-7. PubMed ID: 16601540
[TBL] [Abstract][Full Text] [Related]
4. [Osteoporosis: whom, when and how to treat?].
Stepán J
Cas Lek Cesk; 2009; 148(1):25-33. PubMed ID: 19634279
[TBL] [Abstract][Full Text] [Related]
5. Is bone mineral density predictive of fracture risk reduction?
Cefalu CA
Curr Med Res Opin; 2004 Mar; 20(3):341-9. PubMed ID: 15025843
[TBL] [Abstract][Full Text] [Related]
6. Clinical use of serum and urine bone markers in the management of osteoporosis.
Srivastava AK; Vliet EL; Lewiecki EM; Maricic M; Abdelmalek A; Gluck O; Baylink DJ
Curr Med Res Opin; 2005 Jul; 21(7):1015-26. PubMed ID: 16004668
[TBL] [Abstract][Full Text] [Related]
7. Monitoring osteoporosis therapy: bone mineral density, bone turnover markers, or both?
Bonnick SL; Shulman L
Am J Med; 2006 Apr; 119(4 Suppl 1):S25-31. PubMed ID: 16563938
[TBL] [Abstract][Full Text] [Related]
8. Whole bone geometry and bone quality in distal forearm fracture.
Parkinson IH; Fazzalari NL
J Orthop Trauma; 2008 Sep; 22(8 Suppl):S59-65. PubMed ID: 18753891
[TBL] [Abstract][Full Text] [Related]
9. The effects of antifracture therapies on the components of bone strength: assessment of fracture risk today and in the future.
Davison KS; Siminoski K; Adachi JD; Hanley DA; Goltzman D; Hodsman AB; Josse R; Kaiser S; Olszynski WP; Papaioannou A; Ste-Marie LG; Kendler DL; Tenenhouse A; Brown JP
Semin Arthritis Rheum; 2006 Aug; 36(1):10-21. PubMed ID: 16887464
[TBL] [Abstract][Full Text] [Related]
10. Is cortical bone hip? What determines cortical bone properties?
Epstein S
Bone; 2007 Jul; 41(1 Suppl 1):S3-8. PubMed ID: 17466615
[TBL] [Abstract][Full Text] [Related]
11. Fracture risk reduction during treatment with teriparatide is independent of pretreatment bone turnover.
Delmas PD; Licata AA; Reginster JY; Crans GG; Chen P; Misurski DA; Wagman RB; Mitlak BH
Bone; 2006 Aug; 39(2):237-43. PubMed ID: 16563890
[TBL] [Abstract][Full Text] [Related]
12. Clinical applications of bone density testing for osteoporosis.
Lewiecki EM
Minerva Med; 2005 Oct; 96(5):317-30. PubMed ID: 16227947
[TBL] [Abstract][Full Text] [Related]
13. Epilepsy, osteoporosis and fracture risk - a meta-analysis.
Vestergaard P
Acta Neurol Scand; 2005 Nov; 112(5):277-86. PubMed ID: 16218908
[TBL] [Abstract][Full Text] [Related]
14. Effects of high bone turnover on the biomechanical properties of the L3 vertebra in an ovine model of early stage osteoporosis.
Kennedy OD; Brennan O; Mahony NJ; Rackard SM; O'Brien FJ; Taylor D; Lee CT
Spine (Phila Pa 1976); 2008 Nov; 33(23):2518-23. PubMed ID: 18978592
[TBL] [Abstract][Full Text] [Related]
15. The prevention and treatment of osteoporosis: a review.
Cosman F
MedGenMed; 2005 May; 7(2):73. PubMed ID: 16369451
[TBL] [Abstract][Full Text] [Related]
16. Technology insight: noninvasive assessment of bone strength in osteoporosis.
Bouxsein ML
Nat Clin Pract Rheumatol; 2008 Jun; 4(6):310-8. PubMed ID: 18431371
[TBL] [Abstract][Full Text] [Related]
17. Screening for osteoporosis in the adult U.S. population: ACPM position statement on preventive practice.
Lim LS; Hoeksema LJ; Sherin K;
Am J Prev Med; 2009 Apr; 36(4):366-75. PubMed ID: 19285200
[TBL] [Abstract][Full Text] [Related]
18. Clinical assessment of fracture risk and novel therapeutic strategies to combat osteoporosis.
Nanes MS; Kallen CB
Fertil Steril; 2009 Aug; 92(2):403-12. PubMed ID: 19559412
[TBL] [Abstract][Full Text] [Related]
19. [Increase in bone mineral density and its effect on fracture risk].
Sone T
Clin Calcium; 2005 Apr; 15(4):625-9. PubMed ID: 15802775
[TBL] [Abstract][Full Text] [Related]
20. Reconsidering the effects of antiresorptive therapies in reducing osteoporotic fracture.
Chesnut CH; Rosen CJ;
J Bone Miner Res; 2001 Dec; 16(12):2163-72. PubMed ID: 11760829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
